Physician profile
Michelle E Petersen
NPI 1811972458
$479.71
in general payments reported to CMS, 2019-2025
13 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.25 · 2022: $71.18 · 2023: $52.48 · 2024: $116 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $84.80 | 2021-2025 | Airsupra |
| Astellas Pharma US INC | $61.14 | 2022-2023 | Xtandi |
| Amgen INC. | $54.96 | 2024-2025 | Evenity |
| Abbvie INC. | $43.22 | 2024 | |
| Teleflex LLC | $40.78 | 2025 | Quikclot |
| Lilly USA, LLC | $35.33 | 2022-2024 | Mounjaro, Zepbound |
| Mylan Specialty L.P. | $30.36 | 2021 | |
| Urogen Pharma, INC. | $29.42 | 2025 | |
| 180 Medical, INC. | $27.61 | 2023 | Gentlecath Glide |
| Pfizer INC. | $24.93 | 2025 | |
| Merck Sharp & Dohme LLC | $19.21 | 2022 | |
| Organogenesis INC. | $16.77 | 2021 | |
| Medtronic, INC. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.